Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project.

Hans-Jürgen HurtzHans TeschThomas GöhlerUlrich HutzschenreuterJohanna HardeLisa KruggelMartina JänickeNorbert Marschnernull null

Published in: Breast cancer research and treatment (2017)

Our data show that most patients with breast cancer have persistent impairments negatively influencing their daily life even 3 years after treatment. Furthermore, we highlight areas requiring special attention in follow-up care.

Keyphrases

quality improvement
healthcare
palliative care
working memory
electronic health record
physical activity
big data
pain management
machine learning
deep learning
childhood cancer